We are live on ! Find out more
First Manhattan

First Manhattan Portfolio holdings

AUM $36.1B
1-Year Est. Return 11.5%
This Fund
S&P 500
This Quarter Est. Return
+1.7%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$16.3B
AUM Growth
+$25M
Cap. Flow
-$106M
Cap. Flow %
-0.65%
Top 10 Hldgs %
42.65%
Holding
1,605
New
145
Increased
276
Reduced
350
Closed
72

Top Buys

Rank Stock Value
1
NWL icon
Newell Brands
NWL
+$126M
2
AAPL icon
Apple
AAPL
+$103M
3
AGN
Allergan plc
AGN
+$86.3M
4
RHI icon
Robert Half
RHI
+$50M
5
FDX icon
FedEx
FDX
+$44.5M

Sector Composition

Rank Sector Weight
1 Financials 34.94%
2 Healthcare 14.28%
3 Industrials 8.82%
4 Technology 7.85%
5 Consumer Staples 6.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.A icon
1
Berkshire Hathaway Class A
BRK.A
$1.06T
$3.21B 19.73%
14,803
-42
-0.3% -$9.01M
BN icon
2
Brookfield
BN
$101B
$584M 3.59%
49,502,799
-438,017
-0.9% -$5.24M
MSFT icon
3
Microsoft
MSFT
$2.83T
$408M 2.51%
7,974,066
+108,933
+1% +$5.66M
BRK.B icon
4
Berkshire Hathaway Class B
BRK.B
$1.06T
$402M 2.47%
2,778,750
+92,851
+3% +$13.3M
AAPL icon
5
Apple
AAPL
$4.72T
$357M 2.2%
14,957,480
+4,144,100
+38% +$103M
BUD icon
6
AB InBev
BUD
$155B
$329M 2.02%
2,496,455
-2,565
-0.1% -$323K
JNJ icon
7
Johnson & Johnson
JNJ
$624B
$322M 1.98%
2,654,177
-51,391
-2% -$5.84M
ZBH icon
8
Zimmer Biomet
ZBH
$17.3B
$306M 1.88%
2,618,885
-37,236
-1% -$4.21M
CVS icon
9
CVS Health
CVS
$136B
$284M 1.74%
2,963,676
-107,149
-3% -$10.7M
DHR icon
10
Danaher
DHR
$135B
$261M 1.6%
3,839,592
-22,931
-0.6% -$1.5M
WFC icon
11
Wells Fargo
WFC
$261B
$242M 1.49%
5,108,465
-60,951
-1% -$2.97M
HON icon
12
Honeywell
HON
$78B
$236M 1.45%
2,258,590
-19,911
-0.9% -$2.05M
ARMK icon
13
Aramark
ARMK
$15B
$215M 1.32%
8,913,392
-231,504
-3% -$5.57M
CMCSA icon
14
Comcast
CMCSA
$78.3B
$211M 1.29%
6,463,074
-43,734
-0.7% -$1.36M
PM icon
15
Philip Morris
PM
$298B
$176M 1.08%
1,729,417
-33,691
-2% -$3.36M
GILD icon
16
Gilead Sciences
GILD
$162B
$169M 1.04%
2,031,292
+359,484
+22% +$31.9M
PFE icon
17
Pfizer
PFE
$143B
$163M 1%
4,882,141
-3,903,648
-44% -$125M
AGN
18
DELISTED
Allergan plc
AGN
$160M 0.99%
694,036
+374,443
+117% +$86.3M
ORCL icon
19
Oracle
ORCL
$346B
$153M 0.94%
3,746,761
-785,082
-17% -$31.3M
NWL icon
20
Newell Brands
NWL
$2.14B
$136M 0.83%
2,796,704
+2,690,434
+2,532% +$126M
AIG icon
21
American International
AIG
$41.4B
$134M 0.82%
2,528,755
-68,318
-3% -$3.77M
MMM icon
22
3M
MMM
$87.5B
$132M 0.81%
904,798
-5,979
-0.7% -$843K
ACN icon
23
Accenture
ACN
$84.9B
$131M 0.81%
1,160,233
-22,838
-2% -$2.65M
IBM icon
24
IBM
IBM
$194B
$126M 0.77%
865,562
-6,201
-0.7% -$888K
SCI icon
25
Service Corp International
SCI
$10.9B
$125M 0.77%
4,619,850
+73,257
+2% +$1.93M

Similar funds

First Manhattan's Q2 2016 Portfolio in Review

As of Q2 2016, First Manhattan held 1,605 positions worth $16.3B, up 0.15% from $16.3B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

First Manhattan's Q2 2016 filing shows 145 new, 276 increased, 350 reduced and 72 closed positions. Its largest new stake was Liberty Media Corporation Series C Liberty SiriusXM Common Stock: 1,402,090 shares worth $33M. The largest sale was Perrigo, an estimated $171M.

By sector, the portfolio is most concentrated in Financials at 35% of assets, up from 35% a quarter earlier, followed by Healthcare and Industrials.

  • First Manhattan's largest Q2 2016 buy was Liberty Media Corporation Series C Liberty SiriusXM Common Stock: 1,402,090 shares worth $33M.
  • First Manhattan added most to Newell Brands in Q2 2016, an estimated $126M increase.
  • First Manhattan's biggest Q2 2016 reduction was Perrigo, cutting an estimated $171M.
  • First Manhattan fully exited JARDEN CORPORATION in Q2 2016, selling an estimated $130M.
  • First Manhattan's ten largest holdings make up 43% of its $16.3B portfolio in Q2 2016.
  • First Manhattan opened 145 new positions and closed 72 in Q2 2016.
  • First Manhattan's portfolio value rose 0.15% quarter-over-quarter to $16.3B.

Based on First Manhattan's 13F filing for Q2 2016, filed 14 Jul 2016.